Abstract
Nitric oxide/peroxynitrite signaling is associated with manifold neurovascular pathogenic cascades that lead to neurodegenerative diseases, including ischemic stroke, Alzheimers disease, and vascular dementia. Considerable evidence suggests that reactive nitrogen species as mediators of nitrosative stress could damage biomolecules and subsequently facilitate the breakdown of the highly-structured cellular machinery. Herein, we focus on nitrosative stress signaling, which is intimately associated with endothelial cell injury and blood-brain barrier damage in stroke and neurodegenerative diseases. Unraveling the detrimental role of nitrosative stress signaling in initiating and driving neurovascular pathogenesis may lead to the development of novel vasoprotective strategies via restorative therapies for brain diseases.
Keywords: Nitrosative stress, endothelium, blood-brain barrier, peroxynitrite, cerebral ischemia, vasoprotection, cerebrovascular disease, Alzheimer's disease, vascular dementia, parkinson disease
Current Drug Targets
Title: Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases
Volume: 13 Issue: 2
Author(s): Rong-Rong Tao, Yue-Long Ji, Ying-Mei Lu, Kohji Fukunaga and Feng Han
Affiliation:
Keywords: Nitrosative stress, endothelium, blood-brain barrier, peroxynitrite, cerebral ischemia, vasoprotection, cerebrovascular disease, Alzheimer's disease, vascular dementia, parkinson disease
Abstract: Nitric oxide/peroxynitrite signaling is associated with manifold neurovascular pathogenic cascades that lead to neurodegenerative diseases, including ischemic stroke, Alzheimers disease, and vascular dementia. Considerable evidence suggests that reactive nitrogen species as mediators of nitrosative stress could damage biomolecules and subsequently facilitate the breakdown of the highly-structured cellular machinery. Herein, we focus on nitrosative stress signaling, which is intimately associated with endothelial cell injury and blood-brain barrier damage in stroke and neurodegenerative diseases. Unraveling the detrimental role of nitrosative stress signaling in initiating and driving neurovascular pathogenesis may lead to the development of novel vasoprotective strategies via restorative therapies for brain diseases.
Export Options
About this article
Cite this article as:
Tao Rong-Rong, Ji Yue-Long, Lu Ying-Mei, Fukunaga Kohji and Han Feng, Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases, Current Drug Targets 2012; 13 (2) . https://dx.doi.org/10.2174/138945012799201649
DOI https://dx.doi.org/10.2174/138945012799201649 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology Disease Modifying Therapeutic Strategies in Alzheimers Disease Targeting the Amyloid Cascade
Current Neuropharmacology Purine Molecules as Hypnogenic Factors Role of Adenosine, ATP, and Caffeine
Central Nervous System Agents in Medicinal Chemistry Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Current Alzheimer Research Testosterone and Cognition in Normal Aging and Alzheimers Disease: An Update
Current Alzheimer Research Substance P in Rheumatic Diseases
Current Rheumatology Reviews Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer’s Disease Patients
Current Alzheimer Research Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials COX-2 Inhibitors Celecoxib and Parecoxib: Valuable Options for Postoperative Pain Management
Current Topics in Medicinal Chemistry Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Assessment of the Aggregation Propensity of the β -amyloid Peptide During the Synthesis and when Free in Solution
Protein & Peptide Letters Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer’s Disease: Implications for the Treatment
Current Genomics Harmaline and its Derivatives Against the Infectious Multi-Drug Resistant Escherichia coli
Medicinal Chemistry An Overview of Notch Signaling in Adult Tissue Renewal and Maintenance
Current Alzheimer Research Integrated Biomarkers for Depression in Alzheimer’s Disease: A Critical Review
Current Alzheimer Research The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration
CNS & Neurological Disorders - Drug Targets NOAC in Acute Coronary Syndrome and AF?
Cardiovascular & Hematological Disorders-Drug Targets The Metabolic Syndrome and HIV Infection
Current Pharmaceutical Design Impaired Insulin Sensitivity and Secretion in Patients with Alzheimer’s Disease: The Relationship with Other Atherosclerosis Risk Factors
Current Vascular Pharmacology The Role of Immune and Inflammatory Mechanisms in ALS
Current Molecular Medicine